Work

Characterization of pomiferin triacetate as a novel mTOR and translation inhibitor

Year: 2014

Type: article

Source: Biochemical Pharmacology

DOI: 10.1016/j.bcp.2014.01.034

Authors: Magdalena M. Bajer, Michael M. Kunze, Johanna S. Blees, Heidi R. Bokesch, Hanyong Chen, Thilo F. Brauß, Zigang Dong, Kirk R. Gustafson, Ricardo M. Biondi, Curtis J. Henrich, James B. McMahon, Nancy H. Colburn, Tobias Schmid, Bernhard Brüne

Institutions: Goethe University Frankfurt, Frederick National Laboratory for Cancer Research, National Cancer Institute, Center for Cancer Research, Leidos Biomedical Research Inc. (United States), University of Minnesota, University Hospital Frankfurt

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Center for Cancer Research, Frederick National Laboratory for Cancer Research, Deutsche Forschungsgemeinschaft, National Institutes of Health, National Cancer Institute

Awards: G1277665656, G2209449439, G386607036, G5888954722, G6374948078

OpenAlex ID: W2000522159

FWCI: 0.82

Cites: 55

Cited by: 17

Related to: 10